Following a successful clinical trial and multisite pilot, Desert Oasis Healthcare, a medical group affiliated with Heritage Provider Network (HPN) and Rimidi announced a strategic partnership to deliver a disease management platform powered by clinical decision support algorithms for both diabetes care and congestive heart failure across the greater Palm Springs, California area.
Atlanta-based Rimidi is a digital health startup in the Advanced Technology Development Center’s ATDC Signature portfolio of companies. Desert Oasis Healthcare is an integrated healthcare delivery system. The companies have partnered to offer enhanced care for patients with diabetes and congestive heart failure using Rimidi’s software platform. Under the agreement, Heritage Provider Network will offer Rimidi | Diabetes+Me® and Rimidi | CHF to affiliates across its broad network.
“Rimidi’s intuitive and comprehensive diabetes management platform enables us to serve more patients while improving outcomes and positively impacting both patient and provider experience. These results, coupled with Rimidi’s ability to understand and support the needs of frontline clinicians, make them an excellent partner for our healthcare system.” said Dr. Brian Hodgkins, executive vice president of Clinical Operations and Heritage Provider Network Accountable Care Organization.
Rimidi empowers healthcare systems to deliver more efficient care to patients with chronic diseases, decreasing the financial burden to healthcare system and patients while improving patient quality of life. Rimidi’s Diabetes+Me® cloud-based data analytics platform allows clinicians to make personalized medical decisions and model the effect of treatment changes on individual patient outcomes. Rimidi CHF brings the same focus on personalized medicine and evidence-based care to patients with heart failure.
“Desert Oasis Healthcare is an example for the rest of the country of how to deliver value-based care by optimizing the role of patients and providers through novel delivery models supported by innovative technologies,” said Dr. Lucienne Ide, Rimidi’s CEO. “It has been a tremendous partner to Rimidi and we look forward to continuing to expand our relationship.”
The Diabetes+Me® program is now standard of care for patients with diabetes at HPN in Coachella Valley who can access Rimidi’s application and share data from connected glucose meters and biometric devices. In addition to tracking their health data, patients can use the app to access their care plan and diabetes self-management education online and on mobile devices.
Care teams including nurses, pharmacists and physicians use Rimidi’s unique clinical decision support algorithms to make targeted treatment decisions about patient care and to share that information with the patient via the secure software platform. The platform enables clinicians to make individualized care decisions as supported by clinical evidence and practice guidelines.
Rimidi has received funding from SOURCE, a partnership between the Hitachi Foundation, Investor’s Circle, and Village Capital, as well at the Sorenson Foundation. The company also received funding from the JumpFund, whose mission is to invest women’s capital in female-led companies with growth potential, and from Cox Enterprises.